Stage-specific antimalarial activity of cysteine protease inhibitors

Biol Chem. 2002 May;383(5):843-7. doi: 10.1515/BC.2002.089.

Abstract

Cysteine proteases of the malaria parasite Plasmodium falciparum, known as falcipains, are promising targets for antimalarial chemotherapy. We evaluated cultured parasites for the stage-specific expression of cysteine proteases and sensitivity to cysteine protease inhibitors. Protease activity and inhibitor sensitivity varied markedly over time. Cysteine protease activity was greatest in early trophozoites, while sensitivity to cysteine protease inhibitors was greatest in mature trophozoites. Our results indicate the importance of considering the stage-specific effects of antimalarials and are consistent with the conclusion that the principal antimalarial activity of cysteine protease inhibitors is due to a block in hemoglobin hydrolysis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antimalarials / pharmacology*
  • Cysteine Endopeptidases / biosynthesis
  • Cysteine Endopeptidases / pharmacology
  • Cysteine Proteinase Inhibitors / pharmacology*
  • Electrophoresis, Polyacrylamide Gel
  • Erythrocytes / parasitology
  • Gene Expression Regulation, Developmental
  • Hemoglobins / metabolism
  • Hydrolysis
  • Leucine / analogs & derivatives*
  • Leucine / pharmacology
  • Leupeptins / pharmacology
  • Plasmodium falciparum / drug effects*
  • Plasmodium falciparum / enzymology*
  • Plasmodium falciparum / growth & development
  • Time Factors

Substances

  • Antimalarials
  • Cysteine Proteinase Inhibitors
  • Hemoglobins
  • Leupeptins
  • Cysteine Endopeptidases
  • falcipain
  • Leucine
  • leupeptin
  • E 64